Incidence and risk factors for intravenous immunoglobulin‐related hemolysis: A systematic review of clinical trial and real‐world populations

BACKGROUND: Severe hemolysis rarely occurs in patients receiving intravenous immunoglobulin (IVIG) therapy. A systematic review was performed to assess the incidence of IVIG‐related hemolysis and the impact of patient and product risk factors. STUDY DESIGN AND METHODS: A systematic literature search...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuesta, Hillary, El Menyawi, Ibrahim, Hubsch, Alphonse, Hoefferer, Liane, Mielke, Orell, Gabriel, Susie, Shebl, Amgad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545798/
https://www.ncbi.nlm.nih.gov/pubmed/35916266
http://dx.doi.org/10.1111/trf.17028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545798/
https://www.ncbi.nlm.nih.gov/pubmed/35916266
http://dx.doi.org/10.1111/trf.17028

Ejemplares similares